“Bioethics of Intervention and the Case of Drugs Bevacizumab and Ranibizumab for Retinal Diseases”. Revista Iberoamericana De Bioética, no. 2, Oct. 2016, pp. 1-10, https://doi.org/10.14422/rib.i02.y2016.004.